New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
January 2, 2025 - ANI Pharmaceuticals launched an AB-rated generic version of Takeda’s Motegrity (prucalopride) tablets.
Download PDF
Return to publications
